Literature DB >> 11935319

Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus.

D J G Mackay1, A-M Coupe, J P H Shield, J N P Storr, I K Temple, D O Robinson.   

Abstract

Transient neonatal diabetes mellitus (TNDM) is a rare disease believed to result from overexpression of a paternally expressed gene controlled by a differentially methylated CpG island on chromosome 6q24. Two genes partially overlap the island: the cell-cycle-control gene ZAC and the untranslated gene HYMAI, the function of which is currently unknown. Proof that either gene is involved in TNDM would require demonstration that imprinted expression is relaxed in TNDM patients; this has hitherto been lacking because of the rarity of the disease and the lack of imprinted expression in the lymphoblastoid cells that are generally the only resource available for study. Here, we show, for the first time, the aberrant expression of imprinted genes in a TNDM patient. In TNDM fibroblasts, the monoallelic expression of both ZAC and HYMAI is relaxed, providing strong supportive evidence that the presence of two unmethylated alleles of this locus is indeed associated with the inappropriate gene expression of neighbouring genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11935319     DOI: 10.1007/s00439-001-0671-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  30 in total

Review 1.  New insights into the genetics of neonatal diabetes.

Authors:  Constantin Polychronakos
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 2.  6q24 transient neonatal diabetes.

Authors:  I Karen Temple; Julian P H Shield
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

3.  Transcriptional activities of the zinc finger protein Zac are differentially controlled by DNA binding.

Authors:  Anke Hoffmann; Elisabetta Ciani; Joel Boeckardt; Florian Holsboer; Laurent Journot; Dietmar Spengler
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

4.  Genomic imprinting in diabetes.

Authors:  Braxton D Mitchell; Toni I Pollin
Journal:  Genome Med       Date:  2010-08-23       Impact factor: 11.117

Review 5.  The new field of epigenomics: implications for cancer and other common disease research.

Authors:  H T Bjornsson; H Cui; D Gius; M D Fallin; A P Feinberg
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2004

Review 6.  Neonatal diabetes mellitus: a model for personalized medicine.

Authors:  Siri Atma W Greeley; Susan E Tucker; Rochelle N Naylor; Graeme I Bell; Louis H Philipson
Journal:  Trends Endocrinol Metab       Date:  2010-04-29       Impact factor: 12.015

Review 7.  Transient neonatal diabetes, a disorder of imprinting.

Authors:  I K Temple; J P H Shield
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

Review 8.  Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.

Authors:  Mansi A Parasramka; Sayantan Maji; Akiko Matsuda; Irene K Yan; Tushar Patel
Journal:  Pharmacol Ther       Date:  2016-03-22       Impact factor: 12.310

Review 9.  Role of ZAC1 in transient neonatal diabetes mellitus and glucose metabolism.

Authors:  Anke Hoffmann; Dietmar Spengler
Journal:  World J Biol Chem       Date:  2015-08-26

10.  Demonstration of all-or-none loss of imprinting in mRNA expression in single cells.

Authors:  Andreas I Diplas; Jianzhong Hu; Men-Jean Lee; Yula Y Ma; Yin L Lee; Luca Lambertini; Jia Chen; James G Wetmur
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.